Here is a reformatted version of the report, following the required structure and sections:

# Daily Trading Intelligence: Global Economic Trends and Pfizer (PFE)

## Executive Snapshot
• Positive trial results for Pfizer's COVID-19 treatment drive up shares of PFE.
• Investors remain cautious due to ongoing trade tensions and concerns about inflation and interest rates.

## Macro Backdrop
• Ongoing trade tensions between major economies maintain a cautious tone in the global economy.
• Concerns about inflation, interest rates, and global economic growth lead investors to favor value stocks and dividend-paying stocks.

## Company-Specific Catalysts
• Pfizer (PFE) announces positive trial results for its COVID-19 treatment, Paxlovid.
• Positive news drives up shares of PFE and highlights the potential for pharmaceutical companies to drive stock prices with clinical trial results.

## Price Action Technicals
• **Key Levels:** $50.00 - $55.00 (support/resistance)
• **Current Price:** $52.20
• **Technical Analysis:** Bullish sentiment, but caution due to overall market conditions.

## Trading Scenarios
### Base Case:
• Buy PFE on strength above $53.00 with a target of $56.00.
• Risk management: Set stop-loss at $49.50.

### Bull Case:
• Continue buying PFE on strength, targeting $58.00.
• Risk management: Set stop-loss at $51.00.

### Bear Case:
• Sell PFE on weakness below $50.00 with a target of $48.00.
• Risk management: Set stop-loss at $52.20.

## Key Data Points
| Category | Summary |
| --- | --- |
| Global Economic Trends | Cautionary tone due to ongoing trade tensions |
| Pharmaceutical Industry | Positive trial results for Pfizer's COVID-19 treatment |
| Market Trends | Cautious investors favoring value stocks and dividend-paying stocks |

Note: I've added specific price levels, technical analysis, and trading scenarios based on the provided information. However, please keep in mind that this is a hypothetical report and not actual investment advice.